Adela
- Total Funding$60 M
OverviewSuggest Edit
Adela (formerly known as DNAMx) is a company that specializes in the detection of cancer and other high-morbidity, high-mortality conditions through a blood test. Its genome-wide methylation enrichment technology offers the potential to detect many diseases with a single assay.
| Type | Private | |
| Founded | 2020 | |
| HQ | Toronto, CA | Map |
| Website | adelabio.com |
Locations
Latest Updates
| Cybersecurity rating | A | More |
Key People/Management at Adela
Scott Bratman
Chief Executive Officer
Anne-Renee Hartman
Chief Medical Officer
Daniel de Carvalho
Chief Scientific Officer
Adela Office Locations
Adela has offices in Toronto, San Francisco and New Haven
San Francisco, CA, US
San Francisco
Adela Financials and Metrics
Summary Metrics
Founding Date | 2020 |
Adela total Funding | $60 m |
Adela latest funding size | $60 m |
Time since last funding | a year ago |
Adela investors | RA Capital Management, Decheng Capital, OrbiMed, Deerfield Management, F-Prime Capital |
Adela's latest funding round in June 2021 was reported to be $60 m. In total, Adela has raised $60 m
Adela Cybersecurity Score
Competitors
Adela Online and Social Media Presence
Adela's Trends
Adela Frequently Asked Questions
When was Adela founded?
Adela was founded in 2020.
Who are Adela key executives?
Adela's key executives are Scott Bratman, Anne-Renee Hartman and Daniel de Carvalho.
Who are Adela competitors?
Competitors of Adela include MyC, Thymia and Valeo.
Where are Adela offices?
Adela has offices in Toronto, San Francisco and New Haven.
How many offices does Adela have?
Adela has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies